| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.3 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.073 | 0.3 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.032 | 0.3 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | epigallocatechin-3-monogallate | CTRPv2 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.3 |